Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
ATRA
ATRA
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
ATRA News
Class Action Lawsuit Announced Against Atara Biotherapeutics
5d ago
Globenewswire
Atara Biotherapeutics Faces Class Action Lawsuit Over Securities Fraud
5d ago
Globenewswire
Atara Biotherapeutics Faces Class Action Lawsuit
5d ago
Globenewswire
Class Action Lawsuit Filed Against Atara Biotherapeutics
6d ago
PRnewswire
Atara Biotherapeutics Accused of Misleading Investors in Class Action
6d ago
PRnewswire
Faruqi & Faruqi Investigates Atara Securities Litigation
Mar 23 2026
Globenewswire
Atara Biotherapeutics Reports FY 2025 Earnings Beat Expectations
Mar 17 2026
seekingalpha
Atara Schedules FDA Meeting to Discuss Tab-cel BLA Response
Mar 12 2026
Newsfilter
Lisata Therapeutics to be Taken Private by Kuva Labs
Mar 09 2026
Benzinga
Atara Partners with Pierre Fabre to Address FDA Concerns on Tabelecleucel
Mar 03 2026
stocktwits
Atara Biotherapeutics Shares Rise After FDA Rejection Report
Feb 25 2026
seekingalpha
ATARA BIOTHERAPEUTICS INC - HCRX REVISITS DEADLINE FOR $9 MILLION CASH PAYMENT
Feb 23 2026
moomoo
Atara Biotherapeutics Faces Securities Fraud Investigation
Feb 13 2026
PRnewswire
Pomerantz LLP Investigates Securities Fraud Claims Against Atara Biotherapeutics
Feb 03 2026
Globenewswire
Atara Biotherapeutics Faces Securities Fraud Investigation
Jan 29 2026
PRnewswire
Atara Biotherapeutics Under Investigation After 57% Stock Drop Following FDA Response
Jan 22 2026
PRnewswire
Show More News
